PharmaTelevision - The Ewing Marion Kauffman Foundation: Entrepreneurship and Success

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: The Ewing Marion Kauffman Foundation: Entrepreneurship and Success

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this interview, Lesa Mitchell, VP Kauffman Foundation, Ewing Marion Kauffman Foundation, talks to Dr Fintan Walton about:

• the Foundation’s origins and its focus on entrepreneurship
• its research and policy pathway
• Translational Medicine Alliance
• the Council for American Medical Innovation
• how the Foundation measures success

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

The Ewing Marion Kauffman Foundation origins and its focus on entrepreneurship.

Fintan Walton:

Hello and welcome to PharmaTelevision news review here in San Francisco at the BioPharm America Conference. On this show I have Lesa Mitchell, who is Vice President at the Kauffman Foundation, which is based in Kansas City here in the USA. Welcome.

Lesa Mitchell:

Thank you. Thank you for having me.

Fintan Walton:

Pleasure. And it is, because Kauffman Foundation is a very interesting foundation. It's founder was one of the founders of a pharmaceutical company here in the US. Can you tell us a little bit about the origins of Kauffman Foundation?

Lesa Mitchell:

Sure. Mr. Kauffman essentially worked in the pharmaceutical industry for Lincoln Labs as a Sales Representative and didn't believe that incentive alignments were set up right and so he literally created his own company by grinding up oyster shells in his basement, which became 00.01.11 created the first osteoporosis foundation. And ultimately developed the one of the largest pharmaceutical companies in the US at the time, first billion dollar drugs on the market, listed as a America's 100 best companies was eventually acquired by Hoechst Marion Roussel then became Sanofi-Aventis and obviously now a new company, so we have a, a rich history from Kansas city to Bridgewater, New Jersey to Frankfurt to Paris.

Fintan Walton:

Okay. That's excellent. Now the key thing about the Kauffman Foundation is it's focus as I understand it on entrepreneurship all the various component parts that allows great entrepreneurship to take place?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Richard Seabrook

Vice President

Lesa Mitchell is a Vice President with the Kauffman Foundation. She is responsible for leading the Foundation's initiatives to advance innovations. Mitchell joined the Foundation in 2003. She has been responsible for the Foundation's frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market. Under Mitchell's leadership the Foundation is identifying critical research opportunities, defining and codifying alternative pathways and identifying new models to foster innovation. Prior to joining Kauffman Foundation, Mitchell's professional background included consulting for global pharmaceutical clients such as Takeda and Eli Lilly. She spent twenty years of her career in global executive roles at Aventis and Quintiles. She has a bachelor's degree from the University of Kansas and volunteer's time on various regional boards.

The Ewing Marion Kauffman Foundation

The Ewing Marion Kauffman Foundation is often referred to as one of the largest foundations in the United States -- or as the world's largest foundation devoted to entrepreneurship.